Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In recent years there has been an increasing awareness on the role of P2X7 receptor for extracellular ATP in modulating physiopathological mechanisms in the CNS. In particular, P2X7 was shown to be implicated in neuropsychiatry, chronic pain, neurodegeneration, neuroinflammation. Remarkably, P2X7 was shown to be a "gene modifier" in amyotrophic lateral sclerosis (ALS): the receptor is up-regulated in spinal cord microglia in human and rat at advanced stages of the disease; in vitro, activation of P2X7 exacerbates pro-inflammatory responses in ALS-microglia, as well as toxicity towards neuronal cells. Despite this detrimental in vitro role of P2X7, in P2X7−/−/SOD1-G93A mice the clinical onset of ALS was significantly accelerated and disease progression worsened, thus indicating that the receptor might have some beneficial effects at least at certain stages of disease. In order to clarify this dual action of P2X7 in ALS pathogenesis, in the present work we used the antagonist Brilliant Blue G (BBG), a blood-brain barrier permeable and safe drug already proven to reduce neuroinflammation in traumatic brain injury, cerebral ischemia/reperfusion, neuropathic pain and experimental autoimmune encephalitis. We tested BBG in SOD1-G93A ALS mouse model at asymptomatic, pre-symptomatic and late pre-symptomatic phases of disease. BBG at late pre-onset significantly enhances motoneuron survival and reduces microgliosis in lumbar spinal cord, modulating inflammatory markers such as NF-κB, NADPH oxidase 2, interleukin-1β, interleukin-10 and brain-derived neurotrophic factor. This is accompanied by delayed onset and improved general conditions and motor performance, in both male and female mice, although survival appears not affected. Our results prove the twofold role of P2X7 in the course of ALS, and establish that P2X7 modulation might represent a promising therapeutic strategy by interfering with the neuroinflammatory component of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 2×
“…binding to purinergic P2 receptors is a well-recognized neuronto-microglia alarm molecule, and purinergic signalling is involved in several forms of neurodegeneration and neuroinflammation comprising ALS (Amadio et al., 2011; Hernández et al., 2010; Kettenmann et al., 2011; Volonté et al., 2011).”
BackgroundMicroglia: new roles for the synaptic stripper
Kettenmann, H., Kirchhoff, F., & Verkhratsky, A. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.023 · Cited by 1,173 · cited 2×
“, 2009), or massive ATP release increasingly occurring from injured motor neurons with consequent toxic roles exerted by P2X7 in activated microglia (Kettenmann et al., 2013; Monif et al., 2010), we demonstrated that antagonism of the receptor produces positive outcomes only at a certain stage and rate of progression…”
BackgroundMinocycline selectively inhibits M1 polarization of microglia
Kobayashi, K., Imagama, S., Ohgomori, T., Hirano, K., Uchimura, K., Sakamoto, K., Hirakawa, A., Takeuchi, H., Suzumura, A., Ishiguro, N., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.54 · Cited by 742
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646 · cited 2×
“Inflammation and oxidative stress play central roles in ALS pathogenesis and contribute to a vicious cycle of neurodegeneration when unhealthy motor neurons produce signals that activate microglia to release reactive oxygen species and proinflammatory cytokines (Philips and Robberecht, 2011; Sargsyan et al., 2011).”
BackgroundModulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
The P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374 · cited 2×
“Consistent with low basal levels of ATP release and trophic P2X7 action that have been observed in surveilling microglia (Monif et al., 2009), or massive ATP release increasingly occurring from injured motor neurons with consequent toxic roles exerted by P2X7 in activated microglia (Kettenmann et…”
BackgroundMicroglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353 · cited 2×
“In addition to the dual role played by neuroinflammation and microglia in ALS (Henkel et al., 2009), our data now indicate that P2X7 might also act as a dual modifier in the disease.”
BackgroundRedox modifier genes in amyotrophic lateral sclerosis in mice
Marden, J. J., Harraz, M. M., Williams, A. J., Nelson, K., Luo, M., Paulson, H., & Engelhardt, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31265 · Cited by 145
D'Ambrosi, N., Finocchi, P., Apolloni, S., Cozzolino, M., Ferri, A., Padovano, V., Pietrini, G., Carrì, M. T., & Volonté, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901212 · Cited by 131 · cited 2×
“…tumor necrosis factor α (TNF-α) and levels of COX-2 and MAPKs in ALS-microglia primary cultures, with consequent toxicity towards neuronal cells (Apolloni et al., 2013a; D’Ambrosi et al., 2009), as well as providing a neurotoxic function that is mediated by astrocytes (Gandelman et al., 2010).”
Self-citation
Cited by
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
“Purinergic receptor P2 × 7 is also related to microglia polarization (Apolloni et al., 2014).”
BackgroundInfluentialMicroglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385
“In an ALS mice model (SOD1-G93A), blockade of P2X7 by BBG delayed the course of the disease, decreased microglia proliferation and motor neuron loss, thus improving motor performance and inflammatory parameters [168].”
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
Metadata
- Authors
- Apolloni, S., Amadio, S., Parisi, C., Matteucci, A., Potenza, R. L., Armida, M., Popoli, P., D'Ambrosi, N., & Volonté, C.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2014-01-01
- Volume
- 7
- Issue
- 9
- Pages
- 1101-9
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2108602500
- Cited by
- 118
- References
- 12
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1242/dmm.017038
- The paper
- Apolloni, S., Amadio, S., Parisi, C., Matteucci, A., Potenza, R. L., Armida, M., Popoli, P., D'Ambrosi, N., & Volonté, C. (2014). Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosis. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.017038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.